Retrospective Cohort Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3381-3391
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3381
Figure 1
Figure 1 Schematic depiction of patient selection and exclusion criteria. pts: Patients; lns: Lymph nodes. CT: Computed tomography; MRI: Magnetic resonance imaging; EUS: Endoscopic ultrasonography; FNA: Fine needle aspiration.
Figure 2
Figure 2 Typical examples of lymph nodes with (A) and without (B) a central intranodal blood vessel on color Doppler endoscopic ultrasonography. An apparently visible lymph node was detected in both A and B (arrowheads). A shows a tubular structure that was ≥ 1 mm in diameter and was located toward the center of the lymph node and demonstrated blood flow on color Doppler endoscopic ultrasonography (arrow).
Figure 3
Figure 3 Contrast-enhanced harmonic endoscopic ultrasonography -determined enhancement patterns of the lymph node.
Figure 4
Figure 4 Typical example of a metastatic lymph node that shows heterogeneous enhancement on contrast-enhanced harmonic endoscopic ultrasonography (left, fundamental B mode; right, contrast harmonic mode).
Figure 5
Figure 5 Typical example of a reactive lymph node that shows homogeneous enhancement on contrast-enhanced harmonic endoscopic ultrasonography (left, fundamental B mode; right, contrast harmonic mode).